IMMUTEP LTD-SP ADR (IMMP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IMMP • US45257L1089

2.7 USD
-0.13 (-4.59%)
Last: Feb 4, 2026, 08:28 PM
Fundamental Rating

3

IMMP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 524 industry peers in the Biotechnology industry. While IMMP seems to be doing ok healthwise, there are quite some concerns on its profitability. IMMP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IMMP has reported negative net income.
  • IMMP had a negative operating cash flow in the past year.
  • In the past 5 years IMMP always reported negative net income.
  • IMMP had a negative operating cash flow in each of the past 5 years.
IMMP Yearly Net Income VS EBIT VS OCF VS FCFIMMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • IMMP has a Return On Assets of -24.06%. This is in the better half of the industry: IMMP outperforms 72.33% of its industry peers.
  • IMMP's Return On Equity of -25.43% is fine compared to the rest of the industry. IMMP outperforms 79.20% of its industry peers.
Industry RankSector Rank
ROA -24.06%
ROE -25.43%
ROIC N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
IMMP Yearly ROA, ROE, ROICIMMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IMMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMMP Yearly Profit, Operating, Gross MarginsIMMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20K -40K -60K -80K -100K

More info and screens

6

2. Health

2.1 Basic Checks

  • IMMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IMMP has been reduced compared to 1 year ago.
  • Compared to 5 years ago, IMMP has more shares outstanding
  • Compared to 1 year ago, IMMP has a worse debt to assets ratio.
IMMP Yearly Shares OutstandingIMMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
IMMP Yearly Total Debt VS Total AssetsIMMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • IMMP has an Altman-Z score of 33.33. This indicates that IMMP is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 33.33, IMMP belongs to the best of the industry, outperforming 93.32% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that IMMP is not too dependend on debt financing.
  • IMMP has a Debt to Equity ratio of 0.00. This is comparable to the rest of the industry: IMMP outperforms 49.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 33.33
ROIC/WACCN/A
WACC9.33%
IMMP Yearly LT Debt VS Equity VS FCFIMMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 18.86 indicates that IMMP has no problem at all paying its short term obligations.
  • IMMP has a better Current ratio (18.86) than 95.80% of its industry peers.
  • A Quick Ratio of 18.86 indicates that IMMP has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 18.86, IMMP belongs to the top of the industry, outperforming 95.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 18.86
Quick Ratio 18.86
IMMP Yearly Current Assets VS Current LiabilitesIMMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

  • IMMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.43%.
  • Looking at the last year, IMMP shows a very negative growth in Revenue. The Revenue has decreased by -49.75% in the last year.
  • Measured over the past years, IMMP shows a very negative growth in Revenue. The Revenue has been decreasing by -66.35% on average per year.
EPS 1Y (TTM)-14.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)-49.75%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%-18.07%

3.2 Future

  • Based on estimates for the next years, IMMP will show a very strong growth in Earnings Per Share. The EPS will grow by 28.26% on average per year.
  • IMMP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 131.49% yearly.
EPS Next Y-39.92%
EPS Next 2Y-24.38%
EPS Next 3Y8.6%
EPS Next 5Y28.26%
Revenue Next Year242.67%
Revenue Next 2Y28.2%
Revenue Next 3Y254.58%
Revenue Next 5Y131.49%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMMP Yearly Revenue VS EstimatesIMMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IMMP Yearly EPS VS EstimatesIMMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • IMMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMMP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMMP Price Earnings VS Forward Price EarningsIMMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMMP Per share dataIMMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.38%
EPS Next 3Y8.6%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for IMMP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

IMMUTEP LTD-SP ADR

NASDAQ:IMMP (2/4/2026, 8:28:17 PM)

2.7

-0.13 (-4.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-29
Earnings (Next)02-19
Inst Owners45.28%
Inst Owner Change0.6%
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap397.42M
Revenue(TTM)60.10K
Net Income(TTM)-43.87M
Analysts82.22
Price Target3.3 (22.22%)
Short Float %3.32%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)27.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-23.48%
EPS NY rev (3m)-10.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)235.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10534.91
P/FCF N/A
P/OCF N/A
P/B 3.29
P/tB 3.44
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0
BVpS0.82
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.06%
ROE -25.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1556.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 18.86
Quick Ratio 18.86
Altman-Z 33.33
F-Score2
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y-39.92%
EPS Next 2Y-24.38%
EPS Next 3Y8.6%
EPS Next 5Y28.26%
Revenue 1Y (TTM)-49.75%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%-18.07%
Revenue Next Year242.67%
Revenue Next 2Y28.2%
Revenue Next 3Y254.58%
Revenue Next 5Y131.49%
EBIT growth 1Y-12.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.38%
EBIT Next 3Y27.19%
EBIT Next 5Y33.35%
FCF growth 1Y-10.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.95%
OCF growth 3YN/A
OCF growth 5YN/A

IMMUTEP LTD-SP ADR / IMMP FAQ

What is the ChartMill fundamental rating of IMMUTEP LTD-SP ADR (IMMP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMMP.


Can you provide the valuation status for IMMUTEP LTD-SP ADR?

ChartMill assigns a valuation rating of 0 / 10 to IMMUTEP LTD-SP ADR (IMMP). This can be considered as Overvalued.


How profitable is IMMUTEP LTD-SP ADR (IMMP) stock?

IMMUTEP LTD-SP ADR (IMMP) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for IMMP stock?

The Earnings per Share (EPS) of IMMUTEP LTD-SP ADR (IMMP) is expected to decline by -39.92% in the next year.